AndreaBozzo/ceres-open-data-index huggingface dataset:
ACF Parent Report 2024 - Spanish Version

The Administration for Children and Families (ACF) promotes the economic and social well-being of children, families, and communities across the country. As part of this mission, ACF actively listens to and engages with those it serves to ensure the compassionate and effective delivery of human services. The ACF Parent Engagement Report summarizes recent listening sessions ACF held with parents and caregivers from diverse backgrounds who have a range of experiences with ACF programs. The report shares a glimpse into the insights that parents shared from each of these listening sessions and highlights a few examples of how ACF has been and continues to be responsive to their feedback and recommendations.

Metadata-only record linking to the original dataset. Open original dataset below.
Why do antioxidants fail to provide clinical benefit?

The results of recent randomized trials to test the influence of antioxidants on coronary-event rates and prognosis in patients with coronary-artery disease were disappointing. In none of these studies did the use of vitamin E improve prognosis. In contrast, treatment of coronary-artery disease with angiotensin-converting-enzyme (ACE) inhibitors reduced coronary-event rates and improved prognosis. ACE inhibition prevents the formation of angiotensin II, which has been shown to be a potent stimulus of superoxide-producing enzymes in atherosclerosis. The findings suggest that inhibition of superoxide production at enzymatic levels, rather than symptomatic superoxide scavenging, may be the better choice of treatment.
Compound 525397: 2,7-Dithianonane

Chemical compound data from PubChem database. IUPAC Name: 1-ethylsulfanyl-4-methylsulfanylbutane. Molecular Formula: C7H16S2. Molecular Weight: 164.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529159: 1-Hexanamine, mono-DMTBS

Chemical compound data from PubChem database. IUPAC Name: N-[tert-butyl(dimethyl)silyl]hexan-1-amine. Molecular Formula: C12H29NSi. Molecular Weight: 215.45. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Blue Bikes System Data

Blue Bikes (formerly Hubway) is jointly owned and managed by the municipalities of Boston, Arlington, Brookline, Cambridge, Chelsea, Everett, Malden, Medford, Newton, Revere, Salem, Somerville, and Watertown. This external website provides datasets on Blue Bikes usage. 

It includes: 

- Comprehensive set of trip histories which is updated monthly
- Real time system data,  published in open General Bikeshare Feed Specification (GBFS) format - a format recommended by the North American Bike Share Association (NABSA). 

This data is provided according to the **Blue Bikes Data License Agreement.**
Levonorgetsrel and ethinyl estradiol

Levonorgestrel and Ethinyl Estradiol is a prescription oral contraceptive tablet containing 0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol per dose, packaged in a 28-day blister pack. Manufactured by Camber Pharmaceuticals, Inc., it's used to prevent pregnancy. This information was generated using AI and is provided for informational and research purposes only.
Angiogenesis in the pathogenesis of inflammatory joint and lung diseases

This paper reviews hypotheses about roles of angiogenesis in the pathogenesis of inflammatory disease in two organs, the synovial joint and the lung. Neovascularisation is a fundamental process for growth and tissue repair after injury. Nevertheless, it may contribute to a variety of chronic inflammatory diseases, including rheumatoid arthritis, osteoarthritis, asthma, and pulmonary fibrosis. Inflammation can promote angiogenesis, and new vessels may enhance tissue inflammation. Angiogenesis in inflammatory disease may also contribute to tissue growth, disordered tissue perfusion, abnormal ossification, and enhanced responses to normal or pathological stimuli. Angiogenesis inhibitors may reduce inflammation and may also help to restore appropriate tissue structure and function.
Climate Shield Bull Trout (0% Brook Trout), 1980 (Feature Layer)

This feature class represents the historical (1970-1999) scenario for bull trout, derived from the Climate Shield fish distribution models. These models provide stream-specific probabilistic predictions about the occurrence of juvenile bull trout and cutthroat trout in association with three different scenarios for climate change and brook trout invasions. These datasets indicate all potential cold-water habitats less than 11 degrees Celsius. The attribute fields BT_0BRK - BT_100BRK indicate the probabilities of bull trout occurrence within a cold-water habitat based on the prevalence of brook trout at 0%, 25%, 50%, 75%, or 100% of the sites within a habitat. The probabilities were predicted using the Climate Shield native trout models developed from known species occurrence in greater than 500 cold-water streams. The stream centerlines were based on the National Hydrography Dataset (NHD) but were modified for purposes of modeling and cross-walking to other datasets.
Patent AT-E401376-T1: [Translated] LCST POLYMERS

A description is given of polymers of the general formula in which R<SUB>1 </SUB>(identical or different at each occurrence) is hydrogen or a methyl group, X<SUB>1 </SUB>and X<SUB>2</SUB>=-O-, -S- or -NH- and X<SUB>1 </SUB>additionally is a single bond if the first atom in R<SUB>2 </SUB>is not a carbon atom, and R<SUB>2 </SUB>is one of the radicals indicated below: a) a copolymer radical (Cop) containing at least two structural units -(-O-C<SUB>2</SUB>H<SUB>4</SUB>)<SUB>n</SUB>- (ethylene oxide=EO) and -(-O-C<SUB>3</SUB>H<SUB>6</SUB>-)<SUB>n</SUB>- (propylene oxide=PO) or -(-O-C<SUB>4</SUB>H<SUB>8</SUB>)<SUB>n</SUB>- (butylene oxide=BuO) and -(-O-CH<SUB>2</SUB>-)<SUB>n</SUB>- (methylene oxide=MeO) in a molar ratio of 5 to 95:95 to 5, in which n (identical or different for each structural unit) is approximately 1 to 1000; b) in which Cop is a copolymer radical as defined in (a), and x=1 to 5 and y=1 to 20; c) in which R is an alkyl group, r=(identical or different at each occurrence) 1 to 1000 and s=1 to 500; d) in which o=10 to 4000 and R<SUB>3 </SUB>(identical or different at each occurrence) is hydrogen or alkyl groups having 1 to 5 carbon atoms; e) in which p=5 to 2000; or f) in which q=10 to 4000. A description is also given of processes for their preparation and also of their use for coating particles and nonparticulate substrate surfaces.
Adoption Data 2009

This webpage includes reports on state-specific adoption statistics for fiscal year 2009.

Receiving Adoption Subsidy: 10/1/2008 - 9/30/2009
Adoptive Family Structure: 10/1/2008 - 9/30/2009
Age at Adoption Finalization: 10/1/2008 - 9/30/2009
Prior Relationship of Adoptive Parent(s) to Child: 10/1/2008 - 9/30/2009
Race/Ethnicity of Public Agency Children Adopted: 10/1/2008 - 9/30/2009
Sex of Public Agency Children Adopted: 10/1/2008 - 9/30/2009
Child is Identified as a Special Needs Adoption: 10/1/2008 - 9/30/2009
Time between Termination of Parental Rights (TPR) and Adoption Finalization: 10/1/2008 - 9/30/2009

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 528091: Carbamic acid, 4-methylphenyl, heptyl ester

Chemical compound data from PubChem database. IUPAC Name: heptyl N-(4-methylphenyl)carbamate. Molecular Formula: C15H23NO2. Molecular Weight: 249.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Monthly Cumulative Number and Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction, United States

Monthly Cumulative Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction

• Estimated Number of COVID-19 vaccinations among children 6 months–17 years and adults is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group.

 • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine to protect against serious illness from COVID-19. (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html)
Compound 525847: N,N-Dimethyl-2-phenyl-N'-(3-bromophenyl)-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-bromophenyl)-N,N-dimethyl-2-phenylethanimidamide. Molecular Formula: C16H17BrN2. Molecular Weight: 317.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Nursing Home Cost Report (RHCF): 2016

The Nursing Home Cost Report (RHCF) is a uniform report completed by New York nursing homes to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations (Part 86-2.2), nursing homes are required to file financial and statistical data with DOH annually. The data filed is part of the cost report and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends.
Patent AT-E401030-T1: [Translated] COUPLING FOR CONNECTING A VACUUM CLEANER HOSE TO A PIPE

The invention relates to a coupling (10), particularly for joining a vacuum cleaner hose to a tube or to a handle. In order to create a coupling, which can be coupled in a simple manner and which ensures a secure holding when in the coupled detent connection, the invention provides that a detent lug (22) is attached in a fixed manner to the second tubular coupling element (14), and a flank section (20) of the groove flank (18), said flank section being matched to the size of the detent lug (22), is designed so that it can be displaced by an actuating element (28) between a detent position, in which the detent lug (22) is prevented from coming out of the detent groove (16), and a release position, in which the detent groove (16) is released for removing the detent lug (22) from the detent groove (16). In the inventive solution, the coupling elements (12, 14) can be coupled, in particular, in any or at least in a multitude of mutual positions of rotation. A release of the coupled detent connection is preferably only possible in a specified or only in small number of mutual positions of rotation of both coupling elements (12, 14).
Plan Attributes PUF - PY2015

The Plan Attributes PUF (Plan-PUF) is one of the seven files that make up the Marketplace PUF. The Plan-PUF contains plan-level data on maximum out of pocket payments, deductibles, cost sharing, health savings account (HSA) eligibility, formulary ID, and other plan attributes. These data either originate from the Plans &amp; Benefits template (i.e., template field), an Excel based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated). The issuer can also import data created in other templates (e.g., Network IDs from the Network ID template, Service Area IDs from the Service Area template, and Formulary IDs from the Prescription Drug template) to use as allowable values for the applicable fields in the Plans &amp; Benefits template, or enter these values manually.
Indicators for 2010A

Payment files reflect a change in the conversion factor as a result of the Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, which President Obama signed into law on June 25, 2010. This legislation provides for a 2.2 percent update to the 2010 Medicare Physician Fee Schedule (MPFS), effective for dates of service June 1, 2010, through November 30, 2010. For 2010A: Payment files reflect changes as a result of practice expense (PE) and malpractice (MP) relative value unit (RVU) corrections and provisions of the Patient Protection and Affordable Care Act (the Affordable Care Act), as modified by the Health Care and Education Reconciliation Act of 2010, which President Obama signed into law on March 23, 2010, and March 30, 2010, respectively.
Occurrence of leu

Background
          Many investigations have reported that advantageous mutations occurred more frequently under selective conditions than those under non-selective conditions. This phenomenon is referred to as adaptive mutation. Their characteristics are that adaptive mutations are directed and growth-independent. The idea of directed adaptive mutation had been objected by some reports, however, the idea of growth-independent adaptive mutation has been held till today.
        
        
          Results
          In this paper, we have observed that under leucine starvation conditions, leu+ revertants accumulated as a function of time; leu- to leu+ reverse mutation rates and frequencies were higher than those under non starvation conditions; and no divided cells could be monitored by the penicillin method. These results were similar to the time-dependent manner of adaptive mutation from previous reports. However, leucine concentration determinate experiments revealed that certain traces of leucine, which leaked from the E. coli cells, was almost always present in the culture. More numbers of leu+ revertants appeared when the similar cultures were dropped in small areas on the selective plates than when spread on the whole selective plates. These results have shown that mutations under leucine starving conditions are growth-dependent. Fluctuation analysis of leu+ revertants indicated that leu-leu+ mutation occurred spontaneously and randomly. In addition, the spectra of leuB gene in the revertants proved that mutations under selective conditions were not specific or directed.
        
        
          Conclusions
          The above investigations led to the conclusion (1) that the occurrence of leu+ mutations under starvation conditions was growth-dependent. The occurence mutations was also similar to that under non-starvation conditions (2). Under starvation conditions the mutation rates were higher, and was not constant during the long process.
Nursing Home Cost Report (RHCF): 2014

The Nursing Home Cost Report (RHCF) is a uniform report completed by New York nursing homes to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations (Part 86-2.2), nursing homes are required to file financial and statistical data with DOH annually. The data filed is part of the cost report and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends.
Compound 526017: o-Synephrine, N-DTFMB-TMS

Chemical compound data from PubChem database. IUPAC Name: N-methyl-3,5-bis(trifluoromethyl)-N-[2-trimethylsilyloxy-2-(2-trimethylsilyloxyphenyl)ethyl]benzamide. Molecular Formula: C24H31F6NO3Si2. Molecular Weight: 551.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
A new way to rapidly create functional, fluorescent fusion proteins: random insertion of GFP with an

Background
          The jellyfish green fluorescent protein (GFP) can be inserted into the middle of another protein to produce a functional, fluorescent fusion protein. Finding permissive sites for insertion, however, can be difficult. Here we describe a transposon-based approach for rapidly creating libraries of GFP fusion proteins.
        
        
          Results
          We tested our approach on the glutamate receptor subunit, GluR1, and the G protein subunit, αs. All of the in-frame GFP insertions produced a fluorescent protein, consistent with the idea that GFP will fold and form a fluorophore when inserted into virtually any domain of another protein. Some of the proteins retained their signaling function, and the random nature of the transposition process revealed permissive sites for insertion that would not have been predicted on the basis of structural or functional models of how that protein works.
        
        
          Conclusion
          This technique should greatly speed the discovery of functional fusion proteins, genetically encodable sensors, and optimized fluorescence resonance energy transfer pairs.
Midwest: 2011-2012 NSDUH

This report presents the Midwest\'s (e.g., combines Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin) estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for the Midwest for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Patent AT-E401730-T1: [Translated] AUTHENTICATION FOR WEB SERVICES THROUGH A TRUSTED UNIT

The present invention extends to trusted third party authentication for Web services. Web services trust and delegate user authentication responsibility to a trusted third party that acts as an identity provider for the trusting Web services. The trusted third party authenticates users through common authentication mechanisms, such as, for example, username/password and X.509 certificates and uses initial user authentication to bootstrap subsequent secure sessions with Web services. Web services construct user identity context using a service session token issued by the trusted third party and reconstruct security states without having to use a service-side distributed cache.
Compound 525635: N,N-Dimethyl-N'-nonyl-p-chlorobenzamidine

Chemical compound data from PubChem database. IUPAC Name: 4-chloro-N,N-dimethyl-N'-nonylbenzenecarboximidamide. Molecular Formula: C18H29ClN2. Molecular Weight: 308.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530174: Hippuric acid, 3-hydroxy, TMS, # 1

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-[[trimethylsilyloxy-(3-trimethylsilyloxyphenyl)methylidene]amino]acetate. Molecular Formula: C18H33NO4Si3. Molecular Weight: 411.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529125: 1,2-Propanediol, bis-DMTBS

Chemical compound data from PubChem database. IUPAC Name: tert-butyl-[1-[tert-butyl(dimethyl)silyl]oxypropan-2-yloxy]-dimethylsilane. Molecular Formula: C15H36O2Si2. Molecular Weight: 304.61. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525603: N,N-Dimethyl-N'-(4-methylphenyl)-p-chlorobenzamidine

Chemical compound data from PubChem database. IUPAC Name: 4-chloro-N,N-dimethyl-N'-(4-methylphenyl)benzenecarboximidamide. Molecular Formula: C16H17ClN2. Molecular Weight: 272.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401482-T1: [Translated] ENERGY ABSORBING AND MAGNETIC COUPLING DEVICE

A non-contact apparatus removes translational energy (slows movement) of a first magnetic assembly when it is moved through the magnetic field of a second magnet. The first magnetic assembly contains a magnet that can rotate, such as a diametrically magnetized cylindrical magnet in a cylindrical cavity. Rotation of the first magnet does work against a predetermined drag. The apparatus also forms a non-contact magnetic coupling that holds a predetermined relative position. The apparatus can be used as a door catch that slows down and quietly stops a door at a predetermined position relative to the doorframe.
Patent AT-E400377-T1: [Translated] HYDROFORMING PRESS FOR PRODUCING MOLDED PARTS BY INTERNAL HIGH PRESSURE FORMING

A hydroform press has shrink-joined outer (3) and inner (4) pipes. The inner pipe has a two-part (7, 8) tool mount (6) for an upper (10) and lower (11) tool (9) with a work piece (13) form chamber (12). Short stroke cylinders (14, 15) are located between the tools and tool mounts, and close the tools during the forming process. A pressure cushion (20, 21) is located between the short stroke cylinder pressure pistons (18, 19), the upper and lower tools respectively. The cushions compensate the form chamber (12) inner pressure on the pistons (18, 19) and tools (10, 11). The cushions are integrated in the pistons (18, 19) and/or in the upper and lower tools. Cushion pressure is regulated in accordance with form chamber (12) pressure.
Guanfacine

Guanfacine Hydrochloride is a prescription medication available as extended-release tablets in strengths of 1mg, 2mg, 3mg, and 4mg. It acts as a central alpha-2 adrenergic agonist, commonly used to treat attention deficit hyperactivity disorder (ADHD) in children and adults. Manufactured by Slate Run Pharmaceuticals, LLC, under application ANDA213428. This information was generated using AI and is provided for informational and research purposes only.
2010 CMHS Uniform Reporting System (URS) Output Tables for Puerto Rico

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Trauma Centers

<p>[<a target='_blank' href='https://files.hawaii.gov/dbedt/op/gis/data/fire_stations.pdf' rel='nofollow ugc noopener noreferrer'>Metadata</a>] &nbsp;Trauma Centers: Locations of all Trauma Centers across the State of Hawaiʻi as of December 2025. Source: DOH Emergency Medical Services &amp; Injury Prevention Branch, January 2026. All station information was gathered by DOH EMSIPSB staff members and first responder agencies throughout 2025. This layer includes the names, addresses, and a brief overview of the services provided. Note that this map contains Trauma Centers ONLY – regular, non-trauma hospitals are not included in this analysis. The data is updated yearly, or as necessary. For more information, please see metadata at <a target='_blank' href='https://files.hawaii.gov/dbedt/op/gis/data/fire_stations.pdf' rel='nofollow ugc noopener noreferrer'>https://files.hawaii.gov/dbedt/op/gis/data/fire_stations.pdf </a>or contact (1) Hawaii Statewide GIS Program, Office of Planning and Sustainable Development, State of Hawaii; PO Box 2359, Honolulu, Hi. 96804; (808) 587-2846; email: <a href='mailto:gis@hawaii.gov' rel='nofollow ugc'>gis@hawaii.gov</a>; Website: <a target='_blank' href='https://planning.hawaii.gov/gis' rel='nofollow ugc noopener noreferrer'>https://planning.hawaii.gov/gis</a> or (2) Hawaii State Department of Health, Emergency Medical Services and Injury Prevention Systems Branch; (808) 470-9530; email:<a href='mailto: julie.kobayashi@doh.hawaii.gov' rel='nofollow ugc'> julie.kobayashi@doh.hawaii.gov</a>.</p>